Plandai Biotechnology’s Phytofare Gaining Traction in International Markets
09. Mai 2018 08:30 ET
|
Plandai Biotechnology, Inc.
2018 Focus for U.S. Expansion After Initial Success with NutriBullet LONDON, UNITED KINGDOM, May 09, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (OTC Markets: PLPL) (the...
Plandai Biotechnology’s Phytofare® Utilizes Green Tea to Fight Type 2 Diabetes
03. Mai 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Highly Bioavailable Formulation Efficiently Transfers Antioxidants LONDON, UNITED KINGDOM, May 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandai Biotechnology Discusses How Green Tea Combats Type 2 Diabetes
01. Mai 2018 07:30 ET
|
Plandai Biotechnology, Inc.
Natural Solution Provides Positive Mitigation Against Type 2 Diabetes LONDON, UNITED KINGDOM, May 01, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandai Biotechnology Provides Background on its Past and Present Cannabis Initiatives
25. April 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Company History in Cannabis Research Dates Back to February 2013 LONDON, UNITED KINGDOM, April 25, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandai Biotechnology Discusses Cannabis Strategy, Research and Business
19. April 2018 08:30 ET
|
Plandai Biotechnology, Inc.
LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available...
Plandai Biotechnology Provides Update on its Convertible Debt
12. April 2018 08:00 ET
|
Plandai Biotechnology, Inc.
Previously Issued Convertible Notes Now in Friendly Shareholder Hands LONDON, UNITED KINGDOM, April 12, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandai Biotechnology Addresses Bioavailability and the Science of Phytofare
10. April 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Human Clinical Trial Results and Key Benefits Phytofare Catechin Complex is Superior to Generic Green Tea Extracts LONDON, UNITED KINGDOM, April 10, 2018 (GLOBE NEWSWIRE) -- Plandai...
Plandai Biotechnology Provides Update to Its Proprietary Technology
03. April 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Phytofare Clinically Proven to Dramatically Improve Absorption LONDON, UNITED KINGDOM, April 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandai Biotechnology Appoints Paritz & Company as New Auditor
27. März 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Performing Two Year Audit for Plandaí to Become Current and SEC Compliant LONDON, UNITED KINGDOM , March 27, 2018 (GLOBE NEWSWIRE) -- Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the...
Plandai Biotechnology Issues Business Targets and Milestones for Remainder of 2018
20. März 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Looking to Ramp Commercialization and Accelerate Revenue Growth LONDON, UNITED KINGDOM, March 20, 2018 (GLOBE NEWSWIRE) -- Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...